New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


AbbVie clinches back-to-back clinical wins in ulcerative colitis, lupus

In a double data drop yesterday, AbbVie touted two clinical trial wins. Topline data from the Phase III INSPIRE study showed Skyrizi (risankizumab) met its primary and all secondary endpoints in ulcerative colitis and Rinvoq (upadacitinib) aced its Phase II SLEek trial, showing therapeutic potential in systemic lupus erythematosus.


How the shift to virtual patient care has impacted pharma communications: re-thinking the customer journey

One of the COVID pandemic’s many far-reaching ripple-effects on the healthcare industry is the accelerated adoption of virtual healthcare. Virtual patient care is shaking up our health ecosystem, and it’s forcing our entire industry to re-think the customer journey. Jay Appel discusses a few of the best communication strategies, alternative channels, and messaging adjustments that ad agencies can deploy to help pharma companies support the virtual customer experience – for patients and healthcare professionals.